Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Virus product could kill anthrax and beat antibiotic resistance

07.09.2004


Researchers from Rockefeller University, New York, have developed a new way of killing dangerous bacteria like the ones which cause anthrax and pneumonia, using products from a virus, according to new research presented today (Tuesday, 07 September 2004) at the Society for General Microbiology’s 155th Meeting at Trinity College Dublin.



The new bug-smashing technique uses the bacteria’s own natural enemies, tiny viruses called bacteriophages (or phages), which can infect bacterial cells. The phages make thousands of copies of themselves inside infected bacteria, but then need to dissolve the bacteria’s cell wall to get out and infect other bacterial cells.

“We realised that bacteria have no effective natural defences against these phages once they have been infected,” says Professor Vincent Fischetti of Rockefeller University. “After infection, the phages make an enzyme to dissolve the bacterial cell walls for release and we found that we could use the same enzyme to attack and kill the disease bacteria responsible for pneumonia, anthrax or strep throat.”


The enzymes work on contact, killing the disease bacteria instantly, but without harming other friendly types of bacteria. This offers huge advantages over conventional antibiotics, which indiscriminately kill most bacteria, including our useful ones, and which can lead to disease resistance building up if used too frequently.

“About half of us normally carry disease bacteria in our nose or throat, but without symptoms, which form the only reservoir for these organisms in the environment, allowing them to travel from person to person until they are able to cause infection in the right individual,” says Prof Fischetti. “Removing these bacteria from people in hospitals, day care centres and nursing homes could have a major impact on disease outbreaks amongst vulnerable people in these settings.”

The novel technique offers medical workers an opportunity to control disease bacteria in a completely new way. So far no resistance has been found to the enzymes, but if it were to occur it would be very rare, much rarer than antibiotic resistance. The enzymes successfully kill antibiotic-resistant bacteria that are causing a major problem in hospitals and nursing homes.

“We now have enzymes that kill all bacteria of a particular type, called Gram-positive bacteria, of the major disease-causing organisms, including bacteria for strep throat, pneumonia, neonatal meningitis, endocarditis and anthrax,” says Prof Fischetti. “Since we have never found any resistance to the enzymes, they can be used safely, long term, even to kill recurrent infections.”

In addition, the scientists are currently carrying out clinical trials of an enzyme which can specifically kill anthrax in the blood. This could be used during a terrorist attack or emergency to save the lives of exposed individuals.

Faye Jones | alfa
Further information:
http://www.sgm.ac.uk

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>